Filter
57
Text search:
oms/who
Featured
Recommendations
2
New Publications
14
Language
Document type
No document type
27
Guidelines
18
Studies & Reports
8
Manuals
1
Training Material
1
Brochures
1
Fact sheets
1
Countries / Regions
Brazil
13
Paraguay
5
Venezuela
5
Latin America and the Carribbean
4
Mozambique
3
Benin
3
Argentina
2
Burkina Faso
1
Senegal
1
Haiti
1
Dominican Republic
1
Middle East and North Africa
1
Africa
1
Global
1
Authors & Publishers
Publication Years
Category
Countries
34
Clinical Guidelines
5
Women & Child Health
2
Public Health
1
Key Resources
1
Toolboxes
COVID-19
15
HIV
7
TB
4
Mental Health
2
Pharmacy
2
Disability
1
Cholera
1
Polio
1
Zika
1
Planetary Health
1
NTDs
1
Malaria
1
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
Strengthening surveillance for Variant of Concern (VOC) Omicron (B.1.1.529): technical brief and priority actions for member states World Health Organization Headquarters, 28 November 2021
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
Checklist for risk and impact management of pandemics of COVID-19
Facilitator's Manual - Inter-action Review on the response to COVID-19 - 28 April 2021
Evaluation of the effectiveness of vaccines against COVID-19
INTERIM GUIDANCE 17 MARCH 2021
TECHNICAL SPECIFICATIONS FOR TEST SELECTION ESSENTIAL IN VITRO DIAGNOSTIC TESTS FOR SARS-COV-2
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Para a elaboração deste documento, o Grupo de Farmacovigilância da Rede Pan-americana para a Harmonização Farmacêutica (PARF) baseou-se na perspectiva da OPAS/OMS, a qual considera a Farmacovigilância como componente essencial dos programas de saúde pública (3). Trabalhou-se com a intençã
...
El grupo de Farmacovigilancia de la red Panamericana para la Armonización Farmacéutica (PARF) de la Organización Panamericana de la Salud (OPS), ha desarrollado este documento desde la visión OPS/OMS, considerando que la farmacovigilancia es un componente esencial de los programas de salud públ
...
